Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
2019 Growth Opportunities in Medtech Across Patient Centricity, Technology Adoption, Data Democratization and Invasion by Non-traditional Participants
* Required Fields
Pay by invoice
The study is a comprehensive analysis of the key forces shaping the global medtech industry in 2018 and the resultant themes that would govern the market dynamics in 2019 and beyond. The key medtech industry challenges of lack of innovation in conventional segments, increasing focus on efficiencies, changing device ecosystem to digital enablers, emergence of GAFAM and other non-traditional participants, and growing domestic competition in certain growth markets, has led to certain industry moves broadly classified into increasing personalization, data and tech leverage, enhanced post-acute care coordination and an increasing focus on value-based care models. The intersection of various trends and challenges has led to the emergence of four key themes, as explained below: • Patient Centricity: With shifting focus to proactive patient care, 25% of the top companies and 45% of start-ups are exploring patient-care gaps across the care continuum; • Tech Convergence: Medtech has leveraged on emerging technologies, such as Artificial Intelligence (AI) and Augmented Reality (AR)/Virtual Reality (VR) with 15% to 25% increase in tech-related strategic spending in 2018; • Data Monetization: Emergence of the “Quantified Self” has led to data-driven commercialization, and risk-sharing models will dominate medtech strategies in 2019; and• Non-traditional (NT) Entrants: Entry of tech, automotive, and logistics participants in medtech and the broader healthcare space has led OEMs to evaluate their impact and opportunities.Globally, 2019 will be a year of value-based care, as ‘outcome-based care’ focus will globalize. This will trigger the maturation of risk sharing in solution contracting between providers and drug/device OEMs, driving business value for providers. Access to affordable and quality care will be key political agendas for the upcoming 2019 elections in emerging markets, such as Asia, Africa, and Central and Eastern European countries. Research and Development (R&D) investments in future devices will be more targeted to meet the unique needs of emerging markets. Non-traditional participants, such as Amazon, Ali Health, Microsoft, and IBM, with digital technologies will provide the required impetus to public health systems to ensure accessibility and affordability of care.Frost & Sullivan estimates that the 4 themes would result in a huge set of new and unprecedented growth opportunities for existing medtech participants. The study highlights a set of 20 such growth opportunities cutting across these themes, with a combined incremental value of $64.10 billion, over and above the $413.90 billion traditional market size, in 2019. The estimates further peg the longer-term growth opportunity to be $173.06 billion by 2024, with a healthy CAGR of 22.0% compared to the traditional market, which is estimated to slow down from the current 5.8% to around 5.2% by 2024.
Market Assessment of Global Refurbished Medical Imaging Equipments
Integrated X-ray Fluoroscopy Market Analysis for Western Europe
Internet-delivered Therapies and Mobile Health Ushering a New Health Paradigm
Novel Technologies Driving Infectious Disease Management
Medical Device Innovations Furthering FemTech
Technologies Transforming the Biomanufacturing Landscape
Recent Innovations in Biopharmaceutical and Biomarker Technologies
Advancements in Gene Editing, Energy Harvesting, Biomimetics, and Wearable Devices
Fiducial Markers for Lung and Prostate Cancer in Europe and US, Forecast to 2022
Innovations in Digital Health, Biomanufacturing, Biopharmaceuticals, Genomics, and Diagnostics
medical robots market
solar energy market
glucose monitoring devices market
medical supplies market
diabetes care devices market
fuel cell market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.